HOME >> MEDICINE >> NEWS
Reassuring Findings About Infants Exposed To Zidovudine

Children exposed to zidovudine (ZDV, AZT) in utero and as newborns and who escaped acquiring HIV from their infected mothers show no cancers or other adverse health effects up through preschool age, according to a new study from the National Institutes of Health (NIH). It is the first report to assess the late effects of AZT exposure in healthy HIV-uninfected children born to mothers who took the drug to prevent transmitting HIV to their offspring.

The study, sponsored by the Pediatric AIDS Clinical Trials Group (PACTG) and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), appears in the Jan. 13 issue of the Journal of the American Medical Association.

"These data are critically important because the current recommendation is to treat HIV-infected pregnant women with regimens that include AZT to prevent perinatal HIV transmission," says NIAID Director Anthony S. Fauci, M.D. "Although these findings are reassuring," he adds, "we need to continue to monitor these children for long-term adverse effects of the drug." The investigators plan to follow these children until at least age 21.

The 234 HIV-uninfected children evaluated in this report are part of PACTG 219, a long-term follow-up study that includes more than 2,200 children who have been enrolled in PACTG prevention and treatment protocols. The 234 children were born to mothers who participated in PACTG 076. This landmark NIH study showed that AZT can reduce HIV transmission from an infected woman to her infant by approximately two-thirds. The children in PACTG 076 were exposed to AZT or a placebo in utero and during labor and delivery, and also as newborns for six weeks.

The randomized design of PACTG 076 and subsequent follow-up in this study makes it easier to clearly evaluate AZT's potential toxicity, the investigators note. The health of children who received AZT (122 children) can
'"/>

Contact: Laurie K. Doepel
ldoepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Jan-1999


Page: 1 2

Related medicine news :

1. Findings support shorter course of radiation therapy after breast lumpectomy
2. Findings of Griffiths review into allegations of research misconduct fundamentally flawed
3. New Findings On Dopamine Receptor Biology: Implications For Mental Illness
4. New Findings On Asthma And Breastfeeding, Obesity And Asthma And Snoring And Pre-eclampsia At ALA/ATS Meeting
5. Worlds Premier Pharmaceutical Scientists Share Latest R&D Findings
6. Experts To Discuss Findings From New Lewin Group Study In Conference Call Briefing
7. Over 6,000 Technical Presentations Will Reveal New Findings At National Chemists Meeting In Boston, August 23 - 27
8. About 15 percent of major college athletes may have symptoms of eating disorders, study suggests
9. Tip Sheet: Think About Your Health In April
10. Researchers Uncover Clues About Gateway To The Brain
11. News About Osteoporosis: Fruits And Vegetables Prevent Bone Decay

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... ... ... Power to Decide, the campaign to prevent unplanned pregnancy, announced the launch ... support from the HHS Office of Adolescent Health, Innovation Next is a unique accelerator ... on technology-enabled ideas. , This year, five new teams will be selected to participate ...
(Date:10/16/2018)... ... October 16, 2018 , ... CCC ( Compressor Controls Corporation ... operators today announces Total Train Comprehensive Release version 14.1 (TTCR 14.1), available for ... focused on improving cybersecurity defense around turbomachinery. The upgrade process is seamless, ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... its mission to provide simple, easy-to-use software for biopharma companies. By pairing the ... quickly answer those crucial resourcing questions without spending millions of dollars implementing a ...
(Date:10/16/2018)... ... October 15, 2018 , ... LGC ... Fluids, Order Number 205bf, for easier linearity and calibration verification. , The ... linearity, calibration verification and verification of the reportable range for Albumin (ALB), Amylase ...
(Date:10/13/2018)... ... ... At HEI Health, we believe tomorrow’s healthcare can be made affordable today. ... CXO Fall Summit by Marcus Evans. HEI will be hosting an exclusive round table ... leading healthcare providers. , Marcus Evans National Healthcare CXO Summit is the premium ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... ... October 11, 2018 , ... doeLEGAL, a leading provider ... and law firms, today announced it is sponsoring the 2018 ACC Annual Meeting ... how corporate legal departments are using smart data, intelligently delivered to rethink data ...
(Date:10/11/2018)... ... October 11, 2018 , ... In the last four months it has ... families and allowance of six more in USA, China and Japan from three other ... MRI safety and security products. , The patents assigned from QinetiQ include US 7113092, ...
(Date:10/7/2018)... ... ... likes to think about an emergency, even what might seem like small water damage ... professional, a trusted leader in the restoration industry, has a list of tips to help ... a good time for an emergency, but having a few things in order way ahead ...
Breaking Medicine Technology:
Cached News: